Alpine Associates Management Inc. Continues to Hold Holdings in Imperva Inc (IMPV)
Alpine Associates Management Inc. continued to hold its stake in Imperva Inc (NYSE:IMPV) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 819,894 shares of the software maker’s stock at the close of the 2nd quarter. Alpine Associates Management Inc. owned about 2.42% of Imperva worth $33,656,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in IMPV. Ameritas Investment Partners Inc. bought a new stake in shares of Imperva in the 1st quarter worth approximately $102,000. KCG Holdings Inc. acquired a new position in shares of Imperva in the 1st quarter worth approximately $201,000. US Bancorp DE raised its holdings in shares of Imperva by 142.3% in the 1st quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock worth $221,000 after buying an additional 3,163 shares in the last quarter. Principal Financial Group Inc. acquired a new position in shares of Imperva in the 2nd quarter worth approximately $223,000. Finally, Jane Street Group LLC acquired a new position in shares of Imperva in the 1st quarter worth approximately $224,000. Institutional investors own 92.72% of the company’s stock.
A number of equities research analysts recently weighed in on IMPV shares. UBS AG started coverage on Imperva in a report on Tuesday, June 6th. They set a “positive” rating and a $60.00 price target for the company. ValuEngine cut Imperva from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Stifel Nicolaus restated a “hold” rating and issued a $47.00 price target on shares of Imperva in a research report on Friday, July 14th. Stephens restated an “overweight” rating and issued a $61.00 price target (up from $53.00) on shares of Imperva in a research report on Thursday, July 13th. Finally, BidaskClub upgraded Imperva from a “sell” rating to a “hold” rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, eight have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $52.81.
In other news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the sale, the director now directly owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 2.20% of the company’s stock.
Imperva Inc (NYSE IMPV) traded down 4.235% during midday trading on Wednesday, reaching $43.525. 237,825 shares of the company’s stock traded hands. The firm’s 50-day moving average is $44.79 and its 200 day moving average is $45.48. Imperva Inc has a 52-week low of $34.40 and a 52-week high of $57.24. The firm’s market cap is $1.47 billion.
Imperva (NYSE:IMPV) last announced its earnings results on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.15). Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The company had revenue of $74.44 million for the quarter, compared to analysts’ expectations of $74.30 million. During the same period in the prior year, the company earned ($0.23) earnings per share. The company’s revenue for the quarter was up 28.6% on a year-over-year basis. Equities research analysts expect that Imperva Inc will post $0.81 earnings per share for the current fiscal year.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.